145 related articles for article (PubMed ID: 22234795)
21. Does IGF-1 play a role in the etiopathogenesis of non-functioning adrenocortical adenoma?
Bahadir CT; Ecemis GC; Atmaca H
J Endocrinol Invest; 2018 Nov; 41(11):1317-1323. PubMed ID: 29542030
[TBL] [Abstract][Full Text] [Related]
22. Insulin resistance and insulin secretion in non-diabetic acromegalic patients.
Coculescu M; Niculescu D; Lichiardopol R; Purice M
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):308-16. PubMed ID: 17516294
[TBL] [Abstract][Full Text] [Related]
23. Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion.
Bates AS; Evans AJ; Jones P; Clayton RN
Clin Endocrinol (Oxf); 1995 Apr; 42(4):417-23. PubMed ID: 7750196
[TBL] [Abstract][Full Text] [Related]
24. Associations between circulating bone-derived hormones lipocalin 2, osteocalcin, and glucose metabolism in acromegaly.
Zhang Y; Liu M; Chen H; Zhu K; Feng W; Zhu D; Li P
J Endocrinol Invest; 2020 Sep; 43(9):1309-1316. PubMed ID: 32198716
[TBL] [Abstract][Full Text] [Related]
25. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?
Williams CP; Child DF; Hudson PR; Soysa LD; Davies GK; Davies MG; De Bolla AR
J Clin Pathol; 1996 Nov; 49(11):881-8. PubMed ID: 8944605
[TBL] [Abstract][Full Text] [Related]
26. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly.
Freda PU; Shen W; Heymsfield SB; Reyes-Vidal CM; Geer EB; Bruce JN; Gallagher D
J Clin Endocrinol Metab; 2008 Jun; 93(6):2334-43. PubMed ID: 18349062
[TBL] [Abstract][Full Text] [Related]
27. The relationship between urinary calcium, sodium, and potassium excretion and the role of potassium in treating idiopathic hypercalciuria.
Osorio AV; Alon US
Pediatrics; 1997 Oct; 100(4):675-81. PubMed ID: 9310524
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
Fayed A; El Nokeety MM; Heikal AA; Abdulazim DO; Naguib MM; Sharaf El Din UAA;
Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study.
Fredstorp L; Werner S
J Endocrinol Invest; 1993 Apr; 16(4):253-8. PubMed ID: 8514980
[TBL] [Abstract][Full Text] [Related]
30. Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly.
Steffin B; Gutt B; Bidlingmaier M; Dieterle C; Oltmann F; Schopohl J
Eur J Endocrinol; 2006 Jul; 155(1):73-8. PubMed ID: 16793952
[TBL] [Abstract][Full Text] [Related]
31. Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.
Bredella MA; Schorr M; Dichtel LE; Gerweck AV; Young BJ; Woodmansee WW; Swearingen B; Miller KK
J Clin Endocrinol Metab; 2017 Nov; 102(11):4218-4225. PubMed ID: 28945897
[TBL] [Abstract][Full Text] [Related]
32. Random urinary calcium/creatinine ratio for screening hypercalciuria in children with hematuria.
Choi IS; Jung ES; Choi YE; Cho YK; Yang EM; Kim CJ
Ann Lab Med; 2013 Nov; 33(6):401-5. PubMed ID: 24205487
[TBL] [Abstract][Full Text] [Related]
33. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
Helaly GF; Hussein NG; Refai W; Ibrahim M
Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
[TBL] [Abstract][Full Text] [Related]
34. Urinary growth hormone excretion in acromegaly: diagnostic value in mild disease activity.
Main KM; Lindholm J; Vandeweghe M; Skakkebaek NE
Acta Endocrinol (Copenh); 1993 Nov; 129(5):409-13. PubMed ID: 8279221
[TBL] [Abstract][Full Text] [Related]
35. The role of salt abuse on risk for hypercalciuria.
Damasio PC; Amaro CR; Cunha NB; Pichutte AC; Goldberg J; Padovani CR; Amaro JL
Nutr J; 2011 Jan; 10():3. PubMed ID: 21211048
[TBL] [Abstract][Full Text] [Related]
36. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
[TBL] [Abstract][Full Text] [Related]
37. Association between insulin resistance and serum insulin-like growth factor 1 levels in patients with non-remitting major depressive disorder.
Arinami H; Suzuki Y; Watanabe Y; Tajiri M; Tsuneyama N; Someya T
J Affect Disord; 2024 Jan; 344():612-616. PubMed ID: 37802324
[TBL] [Abstract][Full Text] [Related]
38. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
39. Low prevalence of hypercalciuria in Japanese children.
Kaneko K; Tsuchiya K; Kawamura R; Ohtomo Y; Shimizu T; Yamashiro Y; Yamada T; Yamauchi K; Kitagawa T
Nephron; 2002 Jul; 91(3):439-43. PubMed ID: 12119474
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-1 status is associated with insulin resistance in young patients with spinal muscular atrophy.
Brener A; Sagi L; Shtamler A; Levy S; Fattal-Valevski A; Lebenthal Y
Neuromuscul Disord; 2020 Nov; 30(11):888-896. PubMed ID: 33071067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
